Keudell Morrison Wealth Management Buys Shares of 11,929 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Keudell Morrison Wealth Management purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,929 shares of the pharmacy operator’s stock, valued at approximately $107,000.

Several other institutional investors have also recently made changes to their positions in WBA. Redwood Investment Management LLC grew its position in Walgreens Boots Alliance by 0.9% in the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock worth $2,162,000 after acquiring an additional 850 shares in the last quarter. Empirical Finance LLC boosted its position in Walgreens Boots Alliance by 3.5% during the first quarter. Empirical Finance LLC now owns 26,093 shares of the pharmacy operator’s stock valued at $566,000 after buying an additional 888 shares during the period. Inlet Private Wealth LLC boosted its position in Walgreens Boots Alliance by 1.9% during the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after buying an additional 900 shares during the period. Capital Investment Counsel Inc boosted its position in Walgreens Boots Alliance by 6.6% during the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock valued at $186,000 after buying an additional 950 shares during the period. Finally, Continuum Advisory LLC boosted its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $9.27 on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05. The company’s fifty day moving average price is $9.18 and its 200-day moving average price is $12.30. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.67 EPS. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.79%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analysts Set New Price Targets

Several research firms have issued reports on WBA. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Barclays increased their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Jefferies Financial Group decreased their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Bank of America decreased their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Finally, JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.